The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015. Australia hasn’t followed suit, though flib
We members of the to tell us how they handled plateaus and setbacks while they were trying to lose weight. They told us some of the actual nutrition and fitness strategies they used to kick their weight loss back into gear as well as what they did to sta...